Range
- - -
Vol / Avg.
-/97.4K
Div / Yield
-
52 Wk
37.68 - 87.29
Mkt Cap
1.4B
Payout Ratio
-
Open
-
P/E
-
EPS
-0.74
Shares
22.2M
Outstanding
22.2M
Total Float
17.7M
load more
Sector: Health Care.Industry: Biotechnology
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is a gene therapy company dedicated to developing and commercialising novel treatments for patients suffering from dermatological diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.680-0.740 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
KRYSKrystal Biotech0%1.4B

Krystal Biotech Frequently Asked Questions

Q

How do I buy Krystal Biotech (KRYS) stock?

A

You can purchase shares of Krystal Biotech (NASDAQ: KRYS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Krystal Biotech's (KRYS) competitors?

Q

What is the target price for Krystal Biotech (KRYS) stock?

A

The latest price target for Krystal Biotech (NASDAQ: KRYS) was reported by HC Wainwright & Co. on March 1, 2021. The analyst firm set a price target for 103.00 expecting KRYS to rise to within 12 months (a possible 62.46% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Krystal Biotech (KRYS)?

A

The stock price for Krystal Biotech (NASDAQ: KRYS) is $63.4 last updated Tue Jun 15 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Krystal Biotech (KRYS) pay a dividend?

A

There are no upcoming dividends for Krystal Biotech.

Q

When is Krystal Biotech (NASDAQ:KRYS) reporting earnings?

A
Krystal Biotech’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Krystal Biotech (KRYS) going to split?

A

There is no upcoming split for Krystal Biotech.

Q

What sector and industry does Krystal Biotech (KRYS) operate in?

A

Krystal Biotech is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.